Rapid COVID-19 test put to the test in Real-World clinics

NCT ID NCT05506618

Completed Diagnosis Sponsor: LumiraDx UK Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study evaluates how well the LumiraDx SARS-CoV-2 Ag ULTRA test detects COVID-19 when used at point-of-care locations like clinics or pharmacies. Participants with COVID-19 symptoms provide nasal and nasopharyngeal swabs, and the test results are compared to a standard lab reference method. The goal is to see if this rapid test can reliably identify infections quickly and accurately.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If accurate, this test could provide fast, reliable COVID-19 diagnosis at clinics or pharmacies, helping to quickly identify infections.
What could go wrong: The test may not be as accurate as lab tests, and results depend on sample quality and timing of symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19

Contacts and locations

Locations

Advanced Investigative Medicine

Hawthorne, California, 90250, United States
Cahaba Research, Inc.

Birmingham, Alabama, 35242, United States
Cyn3rgy Research

Gresham, Oregon, 97030, United States
Healthy Life Research, Inc.

Miami, Florida, 33175, United States
The Machuca Foundation, Inc.

Las Vegas, Nevada, 89104, United States
Zion Urgent Care

Katy, Texas, 77494, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.